Vertex Pharmaceuticals Incorporated (VX1.DE)
EUR 441.4
(4.23%)
EUR 441.4
(4.23%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.61 Billion USD | 23.37% |
| 2022 | 3.48 Billion USD | -10.44% |
| 2021 | 3.89 Billion USD | 49.66% |
| 2020 | 2.59 Billion USD | 7.75% |
| 2019 | 2.41 Billion USD | 22.24% |
| 2018 | 1.97 Billion USD | 8.42% |
| 2017 | 1.82 Billion USD | 22.98% |
| 2016 | 1.48 Billion USD | 7.81% |
| 2015 | 1.37 Billion USD | 18.29% |
| 2014 | 1.16 Billion USD | -9.38% |
| 2013 | 1.28 Billion USD | 3.07% |
| 2012 | 1.24 Billion USD | 12.14% |
| 2011 | 1.1 Billion USD | 34.32% |
| 2010 | 825.21 Million USD | 21.36% |
| 2009 | 679.98 Million USD | 9.99% |
| 2008 | 618.2 Million USD | 3.42% |
| 2007 | 597.78 Million USD | 39.16% |
| 2006 | 429.57 Million USD | 46.85% |
| 2005 | 292.53 Million USD | 24.85% |
| 2004 | 234.3 Million USD | -1.85% |
| 2003 | 238.71 Million USD | -5.42% |
| 2002 | 252.4 Million USD | 28.77% |
| 2001 | 196.01 Million USD | 73.88% |
| 2000 | 112.72 Million USD | 7.77% |
| 1999 | 104.6 Million USD | 28.66% |
| 1998 | 81.3 Million USD | 22.07% |
| 1997 | 66.6 Million USD | 43.84% |
| 1996 | 46.3 Million USD | -11.47% |
| 1995 | 52.3 Million USD | 19.41% |
| 1994 | 43.8 Million USD | 43.14% |
| 1993 | 30.6 Million USD | 84.34% |
| 1992 | 16.6 Million USD | 56.6% |
| 1991 | 10.6 Million USD | 65.63% |
| 1990 | 6.4 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.33 Billion USD | 326.03% |
| 2024 Q1 | 1.13 Billion USD | -5.19% |
| 2023 Q4 | 1.19 Billion USD | 11.17% |
| 2023 Q2 | 1.04 Billion USD | 6.57% |
| 2023 Q1 | 983.7 Million USD | 2.31% |
| 2023 FY | 4.29 Billion USD | 23.37% |
| 2023 Q3 | 1.07 Billion USD | 2.43% |
| 2022 Q4 | 961.5 Million USD | 7.82% |
| 2022 FY | 3.48 Billion USD | -10.44% |
| 2022 Q1 | 818.3 Million USD | -13.82% |
| 2022 Q2 | 815.4 Million USD | -0.35% |
| 2022 Q3 | 891.8 Million USD | 9.37% |
| 2021 Q4 | 949.5 Million USD | 37.22% |
| 2021 Q1 | 648.05 Million USD | -4.48% |
| 2021 Q2 | 1.6 Billion USD | 147.17% |
| 2021 FY | 3.89 Billion USD | 49.66% |
| 2021 Q3 | 691.94 Million USD | -56.8% |
| 2020 Q4 | 678.42 Million USD | 0.06% |
| 2020 Q2 | 612.73 Million USD | -2.86% |
| 2020 Q3 | 678.04 Million USD | 10.66% |
| 2020 FY | 2.59 Billion USD | 7.75% |
| 2020 Q1 | 630.78 Million USD | -6.59% |
| 2019 FY | 2.41 Billion USD | 22.24% |
| 2019 Q2 | 535.59 Million USD | 10.08% |
| 2019 Q3 | 715.62 Million USD | 33.61% |
| 2019 Q4 | 675.28 Million USD | -5.64% |
| 2019 Q1 | 486.53 Million USD | -17.69% |
| 2018 Q3 | 467.8 Million USD | -1.48% |
| 2018 Q2 | 474.83 Million USD | 7.83% |
| 2018 Q1 | 440.36 Million USD | -0.25% |
| 2018 Q4 | 591.09 Million USD | 26.35% |
| 2018 FY | 1.97 Billion USD | 8.42% |
| 2017 Q2 | 416.7 Million USD | 7.71% |
| 2017 Q1 | 386.88 Million USD | 7.96% |
| 2017 FY | 1.82 Billion USD | 22.98% |
| 2017 Q4 | 441.45 Million USD | -23.31% |
| 2017 Q3 | 575.65 Million USD | 38.15% |
| 2016 Q4 | 358.36 Million USD | -6.05% |
| 2016 Q1 | 361.07 Million USD | -11.39% |
| 2016 Q2 | 382.66 Million USD | 5.98% |
| 2016 FY | 1.48 Billion USD | 7.81% |
| 2016 Q3 | 381.42 Million USD | -0.32% |
| 2015 Q4 | 407.48 Million USD | 17.75% |
| 2015 Q1 | 301.45 Million USD | 7.67% |
| 2015 FY | 1.37 Billion USD | 18.29% |
| 2015 Q2 | 318.25 Million USD | 5.57% |
| 2015 Q3 | 346.05 Million USD | 8.74% |
| 2014 Q4 | 279.99 Million USD | 5.19% |
| 2014 FY | 1.16 Billion USD | -9.38% |
| 2014 Q2 | 302.22 Million USD | -3.5% |
| 2014 Q3 | 266.16 Million USD | -11.93% |
| 2014 Q1 | 313.17 Million USD | -3.58% |
| 2013 Q2 | 328.97 Million USD | 5.79% |
| 2013 FY | 1.28 Billion USD | 3.07% |
| 2013 Q3 | 316.37 Million USD | -3.83% |
| 2013 Q4 | 324.79 Million USD | 2.66% |
| 2013 Q1 | 310.97 Million USD | -3.89% |
| 2012 Q3 | 297.84 Million USD | -5.16% |
| 2012 Q1 | 307.51 Million USD | -0.26% |
| 2012 Q2 | 314.05 Million USD | 2.13% |
| 2012 Q4 | 323.56 Million USD | 8.63% |
| 2012 FY | 1.24 Billion USD | 12.14% |
| 2011 Q4 | 308.31 Million USD | 2.87% |
| 2011 Q1 | 230.13 Million USD | -0.53% |
| 2011 Q3 | 299.7 Million USD | 10.89% |
| 2011 Q2 | 270.26 Million USD | 17.44% |
| 2011 FY | 1.1 Billion USD | 34.32% |
| 2010 Q4 | 231.36 Million USD | 5.51% |
| 2010 FY | 825.21 Million USD | 21.36% |
| 2010 Q3 | 219.28 Million USD | 11.88% |
| 2010 Q2 | 195.99 Million USD | 9.76% |
| 2010 Q1 | 178.56 Million USD | 6.41% |
| 2009 Q1 | 172.1 Million USD | 1.94% |
| 2009 Q4 | 167.8 Million USD | -0.53% |
| 2009 Q2 | 171.85 Million USD | -0.14% |
| 2009 FY | 679.98 Million USD | 9.99% |
| 2009 Q3 | 168.7 Million USD | -1.83% |
| 2008 Q2 | 156.02 Million USD | 14.55% |
| 2008 FY | 618.2 Million USD | 3.42% |
| 2008 Q3 | 157.15 Million USD | 0.73% |
| 2008 Q4 | 168.81 Million USD | 7.42% |
| 2008 Q1 | 136.2 Million USD | -1.86% |
| 2007 Q1 | 149.11 Million USD | 19.31% |
| 2007 Q4 | 138.79 Million USD | -7.7% |
| 2007 Q3 | 150.36 Million USD | -5.73% |
| 2007 FY | 597.78 Million USD | 39.16% |
| 2007 Q2 | 159.5 Million USD | 6.97% |
| 2006 FY | 429.57 Million USD | 46.85% |
| 2006 Q3 | 110.88 Million USD | 4.99% |
| 2006 Q1 | 88.08 Million USD | 8.78% |
| 2006 Q2 | 105.62 Million USD | 19.91% |
| 2006 Q4 | 124.98 Million USD | 12.71% |
| 2005 Q3 | 74.32 Million USD | 5.92% |
| 2005 Q4 | 80.96 Million USD | 8.93% |
| 2005 Q2 | 70.17 Million USD | 4.64% |
| 2005 Q1 | 67.06 Million USD | 1.76% |
| 2005 FY | 292.53 Million USD | 24.85% |
| 2004 FY | 234.3 Million USD | -1.85% |
| 2004 Q1 | 51.39 Million USD | -58.18% |
| 2004 Q2 | 57.61 Million USD | 12.09% |
| 2004 Q3 | 59.39 Million USD | 3.09% |
| 2004 Q4 | 65.9 Million USD | 10.97% |
| 2003 FY | 238.71 Million USD | -5.42% |
| 2003 Q1 | -112 Thousand USD | -100.16% |
| 2003 Q2 | 105.04 Million USD | 93890.18% |
| 2003 Q3 | 59.55 Million USD | -43.3% |
| 2003 Q4 | 122.9 Million USD | 106.37% |
| 2002 Q4 | 70.84 Million USD | 11.48% |
| 2002 Q3 | 63.55 Million USD | 6.1% |
| 2002 Q1 | 58.11 Million USD | 5.63% |
| 2002 FY | 252.4 Million USD | 28.77% |
| 2002 Q2 | 59.89 Million USD | 3.06% |
| 2001 Q2 | 37.97 Million USD | 12.96% |
| 2001 Q4 | 55.01 Million USD | 9.8% |
| 2001 FY | 196.01 Million USD | 73.88% |
| 2001 Q1 | 33.61 Million USD | 25.7% |
| 2001 Q3 | 50.1 Million USD | 31.96% |
| 2000 FY | 112.72 Million USD | 7.77% |
| 2000 Q4 | 26.74 Million USD | -11.46% |
| 2000 Q3 | 30.2 Million USD | 5.64% |
| 2000 Q2 | 28.59 Million USD | 5.17% |
| 2000 Q1 | 27.18 Million USD | -4.61% |
| 1999 Q4 | 28.5 Million USD | 16.33% |
| 1999 Q2 | 25.9 Million USD | 1.17% |
| 1999 FY | 104.6 Million USD | 28.66% |
| 1999 Q1 | 25.6 Million USD | 0.79% |
| 1999 Q3 | 24.5 Million USD | -5.41% |
| 1998 FY | 81.3 Million USD | 22.07% |
| 1998 Q4 | 25.4 Million USD | 17.59% |
| 1998 Q3 | 21.6 Million USD | 20.67% |
| 1998 Q2 | 17.9 Million USD | 9.15% |
| 1998 Q1 | 16.4 Million USD | -12.3% |
| 1997 FY | 66.6 Million USD | 43.84% |
| 1997 Q4 | 18.7 Million USD | -7.43% |
| 1997 Q3 | 20.2 Million USD | 42.25% |
| 1997 Q2 | 14.2 Million USD | 6.77% |
| 1997 Q1 | 13.3 Million USD | 20.91% |
| 1996 FY | 46.3 Million USD | -11.47% |
| 1996 Q4 | 11 Million USD | -0.9% |
| 1996 Q3 | 11.1 Million USD | -9.76% |
| 1996 Q2 | 12.3 Million USD | 3.36% |
| 1996 Q1 | 11.9 Million USD | 3.48% |
| 1995 Q1 | 12 Million USD | -0.83% |
| 1995 FY | 52.3 Million USD | 19.41% |
| 1995 Q4 | 11.5 Million USD | 1.77% |
| 1995 Q3 | 11.3 Million USD | -35.43% |
| 1995 Q2 | 17.5 Million USD | 45.83% |
| 1994 FY | 43.8 Million USD | 43.14% |
| 1994 Q2 | 11.1 Million USD | 14.43% |
| 1994 Q3 | 11.1 Million USD | 0.0% |
| 1994 Q4 | 12.1 Million USD | 9.01% |
| 1994 Q1 | 9.7 Million USD | -7.62% |
| 1993 Q4 | 10.5 Million USD | 28.05% |
| 1993 FY | 30.6 Million USD | 84.34% |
| 1993 Q1 | 5.2 Million USD | 13.04% |
| 1993 Q2 | 6.5 Million USD | 25.0% |
| 1993 Q3 | 8.2 Million USD | 26.15% |
| 1992 Q4 | 4.6 Million USD | 6.98% |
| 1992 FY | 16.6 Million USD | 56.6% |
| 1992 Q3 | 4.3 Million USD | 230.77% |
| 1992 Q1 | 3.6 Million USD | 20.0% |
| 1992 Q2 | 1.3 Million USD | -63.89% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q2 | 2.6 Million USD | 0.0% |
| 1991 Q4 | 3 Million USD | 15.38% |
| 1991 Q3 | 2.6 Million USD | 0.0% |
| 1991 FY | 10.6 Million USD | 65.63% |
| 1990 FY | 6.4 Million USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q4 | -6.4 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BioNTech SE | 2.52 Billion EUR | 36.25% |
| CureVac N.V. | 211.75 Million EUR | -661.308% |
| Biotest Aktiengesellschaft | 136.8 Million EUR | -1078.436% |
| Biotest Aktiengesellschaft | 136.8 Million EUR | -1078.436% |
| BRAIN Biotech AG | 24.94 Million EUR | -6363.654% |
| Formycon AG | 23.73 Million EUR | -6692.652% |
| Heidelberg Pharma AG | 27.81 Million EUR | -5695.61% |
| Medigene AG | 20.54 Million EUR | -7748.588% |